Abstracts

NEUTRALIZING ANTIBODIES AND TRMs PROVIDE ENHANCED AND DURABLE RESISTANCE AGAINST HIV

A broadly cross-reactive neutralizing antibody response is necessary to prevent infection from diverse strains of HIV. Induction of such broadly neutralizing antibodies by vaccination has been challenging but current approaches can induce autologous neutralizing antibodies (nAbs) in various animal models. Here we tested if vaccine-induced nAbs alone or in combination with cellular immune responses can…

HUMAN NK CELLS DEVELOP ANTIGEN-SPECIFIC IMMUNOLOGICAL MEMORY OF HIV

Beyond their ability to eliminate infected cells without the need for prior sensitization, murine, non-human primate and human natural killer (NK) cells have been shown to mediate virus-specific recall responses. However, whether NK cells can mediate HIV antigen-specific immunological memory in humans remains to be demonstrated.  Using calcein acetoxymethyl ester- or flow cytometry-based cytotoxicity assays,…

EFFICACIOUS RHCMV/SIV VECTORS ELICIT BROADLY CROSS-REACTIVE SIV-SPECIFIC CD8+ T CELLS

RhCMV68-1/SIV vaccines demonstrate a profound ability to protect against SIV challenge, with half of all vaccinated rhesus macaques clearing viremia shortly after infection. A hallmark of RhCMV68-1 vaccines is the induction of CD8 T cells that are non-classically restricted, either by MHC-II or MHC-E molecules. MHC-E restricted cells are necessary for RhCMV68-1 mediated protection, and…

PD-1 BLOCKADE AT TIME OF ART WITHDRAWAL FACILITATES EARLY POST-PEAK VIRAL CONTROL

Previous studies evaluating the ability of PD-1 blockade to reduce viral reservoirs in SIV+ monkeys on ART have failed to demonstrate significant therapeutic benefit. Here, we evaluated whether PD-1 blockade, around the time of ART discontinuation, could facilitate induction of long-term post-ART control of SIV replication through the functional enhancement of SIV-specific T cells around…

TRACKING AND PREDICTING REBOUND IN SHIV-INFECTED INFANT MACAQUES AFTER LONG-TERM ART

Breastfeeding transmission accounts for the majority of new pediatric infections and commits infants to lifelong ART, as interruption is typically followed by return of replication and repopulation of reservoirs. A better understanding of the anatomic origin and kinetics of viral rebound during analytical treatment interruption (ATI) could inform the development of alternatives to ART-based strategies…

PERIPHERAL BLOOD SIV/HIV ORIGINATES FROM INFECTED CELLS IN TISSUES

HIV and SIV infected CD4 T cells localize primarily to lymphoid and mucosal tissues, where they constitute >90% of infected cells in chronic infection. While largely assumed, it remains to be established if peripheral blood (PB) viremia originates from these tissues, or from infected cells directly within the vasculature. Here we assessed in rhesus macaques…

THE MATHEMATICS OF HEPATITIS B CURE

Current therapies for HBV infection generate a sterilizing or functional cure in a very small fraction of treated individuals.  Thus, many new therapeutic approaches are under preclinical and clinical development. Here I will show how insights into these new therapies and HBV biology can be gained by mathematically modeling some of the accumulating experimental data.…